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OPERATIONAL DEFINITION OF TERMS 
E – Health An emerging field of health informatics, referring to the 
organization and delivery of health services and 
information using related technologies (Eisenach, 2008). 
 
Data Security  This refers to protective digital privacy measures that are 
applied to prevent unauthorized access to computers, 
databases and websites (Kullger, 2007). 
 
Decision making  This is the process of making agreements on how the 
institution should be rune which is guided by a given rules 
and regulations (Miller et al., 2004). 
 
Performance  The action or process of carrying out or accomplishing an 
action, task, or function (Jain, 2004). 
 
Medical Representative This is a sales person within the pharmaceutical industry. 
Their main job is marketing of pharmaceutical drugs (Kohl, 
2010).  
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ABSTRACT 
Medical representatives play a central role in many companies, spanning the boundary 
between the selling firm and the customer. Medical representative’s requirements and 
training change through years, a fact the influences their performance. The performance 
of medical representatives is a combined measure of performance of the pharmaceutical 
product, and penetration of the product, a situation leading to this study whose aim is to 
investigate factors affecting their performance. There is a disconnect between the 
pharmaceutical companies, the administrators of the drugs, and the users of the.  ICT 
usage, education on pharmaceutical products, age of medical representative and 
consumer perception on the pharmaceutical firm were used in the study to find if they 
influence the performance of medical representatives.  Literature from various scholars in 
related material was reviewed in terms of their contents, contexts, and related to the 
situation at Dawa. The descriptive study conducted in Dawa pharmaceutical company in 
August 2015had 60 medical representatives, 40 chemists, and 3 bio chemists as the 
population for this study. ICT usage had a direct positive effect on the performance of 
medical representatives; education on pharmaceutical products also was found to have an 
effect on the performance of medical representatives. Age of the of the medical 
representative did not have an effect, and neither was perception of the pharmaceutical 
company. The study recommended integrated ICT usage in pharmaceutical companies, 
more training on communication for medical representatives to enhance their 
communication amongst the parties they interact with.  
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CHAPTER ONE 
INTRODUCTION 
1.0 Introduction 
This chapter covers the background of the study, statement of the problem, objectives of 
the study, research problems, the significance of the study, the limitations and the scope 
of the study. 
 
1.1 Background of study 
Performance management is a vital component of human resource management that 
ensures the effective use of scarce resources. Performance management is a continuous 
process of identifying, measuring and developing the performance of individuals or teams 
and aligning that performance to the strategic goals of the organization. Performance 
management has three main functions which are classified as strategic, administrative and 
developmental. The strategic function links the workers’ performance to the overall 
organizational strategy. Administratively, performance management provides valuable 
information to help the managers make important decisions such as salary increments, 
promotions, recognition and rewards (Hongoro & Normand, 2006). 
 
The developmental function of performance management is realized through the 
provision of information on the strengths and weaknesses of health care workers. 
Performance management involves six main steps, which include having knowledge of 
the job and organization mission, performance planning, performance execution, 
performance Determinants of poor performance can be influenced in a variety of ways, 
using various methods at different levels in the health system. The 2006 World health 
report describes three levers to influence workforce performance: job-related 
interventions that focus on individual occupations, support-system related interventions 
and interventions that create an enabling environment and focus on managerial culture 
and organizational arrangements. Using these levers, a further refinement can be made (at 
micro, macro and individual levels), to link these interventions to the determinants of 
poor performance(Ajzen, 1991).  
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The concept of performance management is relatively new in the health sector, 
particularly the pharmaceutical industry, and lacks documented proof of practice. Health 
sector reforms for nearly two decades seek to improve access and strengthen health care 
systems.  Among the reforms implemented is the decentralization of responsibility for 
delivery of health services and management of healthcare workers from the central 
Ministry of Health (MoH) to the local governments. Education primarily uses messages 
to inform and persuade but occasionally can reinforce behavior which is the main job for 
medical representatives. Enforcement uses the law to coerce, punish, or threaten to 
punish in exchange for appropriate behavior, this is the scope of policy and regulators 
and the environment is used to reward desired behavior, to increase benefits, to decrease 
barriers for desired choices, and to decrease the hassles of daily life (Chalker, 2005). 
 
The environment can encourage exchange through the development of a choice with 
comparative advantage, favorable cost-benefit, and the convenience of time and place. 
After the choice is developed, messages are used to describe and advocate. Marketers 
manage through the use of the 4 P's (product, price, place, and promotion): The  product 
consists of the bundle of "goods," or benefits, that a person receives in return for the 
desired behavior. Anything received is considered P4P and can be monetary or 
nonmonetary, tangible or intangible. The price consists of the bundle of "bads," or costs, 
that a person incurs to receive the goods. These also can be monetary or nonmonetary, 
tangible or intangible.Theplace considers the time and location for the exchange to occur. 
It can be a benefit or a cost, depending on its convenience.Thepromotion consists of the 
messages that announce the proposed exchange (the product, the price, the place, and the 
desired behavior) as state by (Rowe, 2005). 
 
According to Smith, (2011) Information Communication Technology (ICT) refers to 
various gadgets that aid in communication. It is a tool that helps in communication 
among persons, governments, businesses and cultures, within and outside it, and, in 
different parts of the world.  ICT is a tool to attaining marketing and not a tool for 
marketing. It is a part of technology that ensures people talk, on a timely and reliable 
manner; it’s effective and efficient use yields development, however, its misuse, leads to 
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disaster. Proper communication enables marketing, and in this case. Proper use of ICT is 
therefore an enabler of sustainable development 
 
Healthcare industries are intensely promoting and adopting ICT to improve patient care, 
as stated by Johnson, (2010) in the medical care realms. Improvement in technology has 
enabled accessibility, availability; affordability and usage of health care services reaching 
more populations than it would have ordinarily reached thus improving marketing of the 
products and services. When ICT is properly used, more patients know of better health 
care services, thus are in charge of their health, and it propels providers to innovate ways 
of countering their problems.  This situation places great demands on the health care 
industry’s information-handling abilities and infrastructure. 
 
Health is at the heart of the Millennium Development Goals (MDG), recognition of the 
fact that health is central to the global agenda of reducing poverty as well as an important 
measure of human development. Three of the eight MDGs are directly health-related; 
Reduce child mortality (goal 4), Improve maternal health (goal 5), Combat HIV and 
AIDS, malaria, and other diseases (goal 6).  The other MDGs include health-related 
targets and reflect many of the social, economic, environmental, and gender-related 
determinants that have an impact on people’s health. The eight MDGs do not work in 
isolation and therefore cannot be treated in isolation. Policy efforts and discussions need 
to consider the broader health determinants that affect people’s lives (WHO, 2005). 
 
Published evidence by (Batchelor and Norrish, 2010) ascertains that a conveyance 
relationship is key in providing acceptable healthcare standards. The idea of using a 
particular technology in relation to a particular medical condition or within an area of the 
health care system and communicating its efficacy to other users of the same information 
has been shown to work. Besides, continue to state, ICT is becoming the catalyst for 
health care; it serves as an essential medium of  communication between patients and 
medical teams.  
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The social, demographic and economic context in which the pharmaceutical industry 
operates is changing dramatically. One role of pharmaceutical research companies is to 
provide information about their medicines to health care professionals. This interaction 
between pharmaceutical representatives and health care professionals is as stated by. 
Elliot (2010) asserts that without the service of medical representation, pharmaceuticals 
would less likely to have the latest, accurate information available regarding prescription 
medicines, which play an increasing role ineffective health care. Direct communication 
between medical representatives and pharmaceutical research companies is a part of the 
wider health care objective of developing medicines that patients use to live longer, 
healthier, and more productive lives. 
 
Communication enables pharmaceutical research companies inform health care 
professionals about the benefits and risks of their products, provide scientific and 
educational information about their use, and obtain information and advice about their 
medicines through consultation with medical experts, and further, pharmaceutical 
marketing ensures timely access to new studies, clinical data, dosing information, and 
updated drug safety profiles. Many physicians find it at least somewhat difficult to stay 
informed about medications or therapies. This poses a challenge: not only do physicians 
need to know about the treatment options available; they also need to keep abreast of 
emerging drug safety and risk information that could affect their prescribing decisions, 
“Pharmaceutical company representatives provide one source of help in bridging this 
information gap by providing physicians with the latest clinical evidence and updated 
drug safety and risk profiles as they develop. This helps speed the translation of clinical 
evidence into clinical practice, and can help improve patient outcomes and eventually the 
MDG that relate to health (Appleyard, 2003). 
 
Marketing in companies determines the volumes of sales, and innovation of new 
products. Pharmaceutical marketing is a very broad sense incorporates how pushing the 
company products in the market and informing the producers of the drugs to produce 
make productions that improve health care.  About 60 per cent of established marketing 
relationships within the pharmaceutical industries fail to function despite having good 
5 
 
products since there lacks communication between the producers and consumers. In this 
sense, the marketing literature points up the lack of familiarity between the partners, the 
distance that separates them or the absence of pre-collaboration experience as the most 
important inhibitors of the process of marketing, further, medical representatives do more 
than pushing products (Appleyard, 2003). 
 
Ahuja (2000) note that medical representative bridge this gap effectively by enhancing 
marketing of products of these companies, and their performance is key. One of the most 
crucial moments in marketing relations within the pharmaceutical industry is ensuring 
that both ends achieve their goals.  The companies gains access to a vast quantity of 
relevant and up-to-date information quickly, easily and cheaply, state however, that the 
availability of information does not guarantee knowledge creation. Knowledge is the end-
result of a complex process of acquisition, interpretation (analysis and evaluation) and 
integration of that information. For pharmaceutical companies to acquire knowledge, they 
have to undergo a complex learning process to transform the information gained from 
marketing into knowledge.   
 
1.1.2 Profile of Dawa Pharmaceuticals Company 
Dawa pharmaceutical company manufactures both human and vetinary medicine; the 
company is based in Nairobi, Kenya and manufactures drugs for Eastern and Central 
African market for over three decades.  The pharmaceutical company, formerly known as 
Dawa Limited, was acquired by Medisel (K) Ltd in August 2004 and has gone major 
renovation in manufacturing facilities with focus on the quality control department. Dawa 
pharmaceutical company has overcome the test of time and thereby nurturing a culture of 
continuously growing and attaining progression in pharmaceutical product and service 
delivery. This was the idea perceived by its directors on realizing opportunity, market 
demands, and capitalizing on a conceptual idea of medicals supply. The  kind of products 
to be manufactured  is informed by  the  Marketing  department  that does  market  
research,  but  mostly  though they operate on the selling  concept. Dawa   pharmaceutical 
management believes in the older staff to market their products since they have the 
company history and a belief that they understand the health marketing dynamics well.  
6 
 
The  cost  of producing  medicine locally  seems  higher than importing  the same 
finished  products from  China  and  India, as a result of high cost of power  and the 
higher taxes imposed on the importation  of  Active Pharmaceutical Ingredients 
(A.P.I).Other challenges such as “ Brief case business” people  who sell counterfeits 
within the pharmaceutical industry, have affected the sale of Dawa pharmaceuticals 
drugs. The company has various departments, which ensure efficacy and efficiency of the 
drugs; Regulatory Affairs department handles quality, the Pharmacy and Poisons 
department, aligns its self to the government regulator and ensures compliance, while 
customer relations department has a dual function of looking inwardly at the staff 
performance, and customer satisfaction. The company has invested heavy in technology 
in terms of equipment and personnel ability.  
 
Marketing performance is a great contributor in the advancement of health care doesn’t 
seem to work at Dawa pharmaceuticals.  The company produces many human medical 
drugs lines key being paracetamol for both adult and pediatric use. Production of 
medicine requires medical representatives to market the medicine to secondary 
consumers in this case stocks such as chemists, and doctors to prescribe the drug to their 
patients, and at times to primary consumers who are patients. Other players are the bio 
chemists who mix the drug portions that enable their manufacturing. Despite the major 
investment, there seems to be a major disconnect between what is produced, and what the 
market actually expects. For measures of marketing performance in the pharmaceutical 
industry  in Europe; the performance of medical representative is not only a measure of 
how much drugs they can market, but a combination of how effective are these drugs in 
enhancing health care, and creating profits for the manufacturer.  
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Figure 1.1.2 Organization Structure Dawa Pharmaceutical Company 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Source: Dawa Pharmaceutical Company, (2015). 
 
1.2 Statement of the Problem 
Pharmaceutical companies worldwide face growing pressures to cut expenses margins 
while research and development costs of new blockbuster drugs are skyrocketing, Tzokas 
and Saren (2007). It is even more difficult to recruit patients to enroll in clinical trials to 
ascertain efficacy of the manufactured drugs, while at the same time the pattern of 
diseases is changing and patients are demanding more personalize care. Medical 
representatives bridge the gap between the producers and consumers of the 
pharmaceutical products, hence communication is key, while facing these challenges, can 
information communication technology improve delivery of service in the humongous 
pharmaceutical industry. 
 
Kenya Medical Research Institute (2014) reports that there seems to be a disconnect 
between the manufactures of the drugs, the administrators of the drugs, and the users of 
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the drugs. As per the pharmaceuticals industry ICT investment trends survey of 113 
companies, 52% of respondents are planning to increase their ICT budgets in 2014, either 
slightly or significantly - witnessing an increase of 23% compared to 2013. The survey 
also shows that the percentage of respondents planning to retain their ICT budgets and 
basic pharmaceutical training at the same level or to reduce by 8% to reach a value of 
27% in 2014.  Could lack of ICT usage as an enabler of communication at Dawa be an 
influencer to the performance of medical representatives?  
 
The role of marketing representative is to ensure the drug produced by pharmaceuticals 
reach the eventual consumer of the drug. Ahuja (2000) noted that medical representative 
bridge this gap effectively by enhancing marketing of products of these companies, and 
their performance is key, consider that one of the most crucial moments in marketing 
relations within the pharmaceutical industry is ensuring that both ends achieve their 
goals, thus the go in between, who is the medical representative is important to both 
parties. How possible is it then to measure the performance of the medical representative. 
It is not possible to measure performance of a medical representative in numerical 
strength, but by the information that they give. Could the ages of medical representatives 
and their knowledge of the pharmaceutical products be an enhancer to their performance? 
 
The gap between necessary care and the critical care patients indicates that new 
medicines cannot be expected to enter into appropriate use based solely on the clinical 
evidence supporting them. Gronroos (2004) considering that one of the most crucial 
moments in marketing relations within the pharmaceutical industry is ensuring that both 
ends achieve their goals.   In the absence of active dissemination of information about 
medicines to both physicians and consumers, what role does a pharmaceutical company 
age play in ensuring that this gap is closed up in the case of Dawa pharmaceuticals?  
Taking into cognition that the environment is dynamic, with brand new pharmaceutical 
companies emerging in the market, what measures has Dawa pharmaceuticals put in 
place to ensure it adequately responds to these market dynamics. 
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1.3 Research Objectives 
1.3.1 Main Objective 
The main objective of this study was to assess factors influencing marketing performance 
of medical representatives in the pharmaceutical industry: A case of Dawa 
pharmaceutical company, Nairobi 
 
1.3.2 Specific Objectives 
The specific objectives of this study were; 
1. To evaluate the effect of ICT usage on performance of medical representatives at 
Dawa Pharmaceuticals Company in Nairobi. 
2. To establish the effect of education of pharmaceutical products on performance of 
medical representatives of  Dawa Pharmaceuticals 
3. To determine the effect of age on the performance of medical representatives of 
Dawa Pharmaceuticals Company in Nairobi. 
4. To examine the effect of public perception on pharmaceutical products on 
performance of medical representatives at Dawa Pharmaceuticals Company in 
Nairobi. 
 
1.4 Research Questions 
In order to achieve the above objectives, the study asked the following questions 
1. What is the effect of ICT usage on the performance of employees at Dawa 
Pharmaceuticals 
2. What effect does education on pharmaceutical products have on the performance of 
medical representatives of Dawa Pharmaceuticals 
3. Does the age of a medical representative influence the performance of medical 
representatives at Dawa Pharmaceuticals  
4. What is the effect of public perception on pharmaceutical industries on the 
performance of medical representatives at Dawa Pharmaceuticals? 
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1.5 Significance of the Study 
1.5.1Dawa Pharmaceuticals Management  
The study may assist Dawa Pharmaceuticals have a broader understanding of the effects 
of information technology, and knowledge of pharmaceutical products on performance of 
medical representatives. The study shall come up with the effects of ICT and product 
knowledge, and, thus advice on the best strategy to employ in implementing it on its 
operations. This may assist the management to know the extent by which to invest 
appropriate ICT infrastructure and staff training within the marketing department. 
 
1.5.2  Pharmaceutical Industry Regulators 
Over recent years the drug discovery pipeline has been a concern for many in the 
pharmaceutical industry. Escalating costs, increasing complexity and a dwindling 
population of drug candidates suggest that traditional research and development methods 
are unlikely to produce enough breakthrough drugs to ensure industry growth. 
The convergence of information and bio-technologies is revolutionizing drug discovery 
and design and may radically alter the economics of the drug discovery over the coming 
years. This study may ascertain if the efficacy of the drugs that they produce. 
 
1.5.3  Policy makers 
Policy implications highlight two issues; the need for better marketing skills in the 
industry and the ongoing development of a social infrastructure for the pharmaceutical 
industry to continue health care uptake for their products. There have been many changes 
within the health realm, enabling real time decision making. The findings will enable 
policy makers to re-strategize and restructure current health policies that correspond to 
current changing world demands. 
 
1.5.4 Academicians and Scholars,  
The findings may act as a reference point to other researchers in the same field thus 
facilitating their studies. To academicians and scholars, the findings of this study may be 
useful to forming the basis for future research on the subject, providing a critical 
examination of the field. The findings of this study will provide future researchers 
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interested in this area with references and relevant literature to complete their research 
work. The study may provide a deeper understanding and training for medical 
representatives aimed at improving their performance. 
 
1.5.5. Medical Representatives 
This study may further inform medical representatives of Dawa Pharmaceuticals the 
important role that they play as bridges between the manufacturer and the consumers of 
the medicine. It may assist them in designing their reports better and probing chemists 
and doctors for more information regarding their products. 
 
1.6     Scope of study 
This study focused on assessing the factors influencing performance of medical 
representatives in the pharmaceutical industry:  The study that was carried out in Dawa 
Pharmaceutical Company limited, human drug production unit, and narrowed down on 
adult paracetamol line drug manufacture at Dawa pharmaceuticals. The target population 
was medical representatives at the pharmaceutical company, chemists, and the company 
bio chemists. The study took place between the months of July to August 2015, in 
Nairobi, Dawa pharmaceuticals plant in Ruaraka, Nairobi.  
 
1.7 Chapter Summary 
Chapter one of this report introduced the space of marketing within the medical realm 
and how to measure their performance. The problem the researcher studied, the research 
objectives questions used, scope of study, and its limitations are discussed.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.0 Chapter Introduction 
The chapter presents literature review which explores the role of pharmaceutical 
marketing. According to Mugenda and Mugenda (2003), review of literature involved the 
systematic identification, location, and analysis of documents containing information 
related to the research problem being investigated. Moreover, literature review helped 
determine new approaches and stimulated new ideas. The chapter further presents critical 
literature and gaps filled, summary and the conceptual framework of the study. 
 
2.1. Theoretical Literature Review 
2.2.1. Motivation-Hygiene Theory 
Herzberg, (1998) identified specific events in a job that made the employees feel 
exceptionally good or bad about their jobs. By identifying these events he felt he could 
better understand employees' behavior. This attempt to explain the factors that motivate 
individuals through identifying and satisfying their individual needs, desires and the aims 
pursued to satisfy these desires.  This theory also known as a two factor content theory is 
based upon the idea that motivation can be dichotomized into hygiene factors and 
motivation factors. 
 
These two separate ‘needs’ are the need to avoid unpleasantness and discomfort and, at 
the other end of the motivational scale, the need for personal development. Shortage of 
factors that positively encourage employees to attain their goals (the motivating factors) 
will cause employees to focus on other, non-job related ‘hygiene’ factors in order to hide 
their failures. The main motivating factors are not in the environment but in the intrinsic 
value put by the employee in achieving the job. This follows therefore that to motivate an 
individual, a job itself must be challenging, have scope for enrichment, be of interest to 
the jobholder and allows them to have personalized ways of accomplishing it (Lukes, 
2000).  
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A lack of motivators leads to over-concentration on hygiene factors, which are those 
negative factors which can be seen and therefore form the basis of complaint and 
concern.  Hygiene factors (often referred to as maintenance factors) lead to dissatisfaction 
with a job because of the need to avoid unpleasantness (Chitetchi, 2011).  They are 
referred to as hygiene factors because they can be avoided or prevented by the use of 
‘hygienic’ methods. They are concerned with factors associated with the job itself but are 
not directly a part out  it, these factors need to be sanitized, by the employee themselves 
with minimal interference by the employer. 
 
Understanding Herzberg’s theory recognizes the intrinsic satisfaction that can be obtained 
from the work itself. It draws attention to job design and makes managers aware that 
problems of motivation may not necessarily be directly associated with the work, but how 
to accomplish the work. Managers’ understanding that factors which demotivate can 
often be related to matters other than the work itself, can lead to improved motivation, 
greater job satisfaction and improved organizational performance by the entire 
workforce. Hygiene factors in the job are which avoid pain from the environment and 
help prevent problems in the future while assisting employees achieve their goals. 
“Workers will strive to avoid the "pains' in the work environment, such as the "pain" 
brought about by a low salary, or uncomfortable work place. They seek basic comfort and 
innovate ways that make it easy to achieve their jobs. Since the maintenance of hygiene is 
short lived, these factors need continual and need not management attention (Jefferson, 
1999). 
 
If the motivation-hygiene theory holds, management not only must provide hygiene 
factors to avoid employee dissatisfaction, but also must provide factors intrinsic to the 
work itself in order for employees to be satisfied with their jobs. The job should have 
sufficient challenge to utilize the full ability of the employee. Employees who 
demonstrate increasing levels of ability should be given increasing levels of 
responsibility. “If a job cannot be designed to allow creativeness and platforms for the 
employee use their full abilities, then the firm should consider automating the task or 
replacing the employee with one who has a lower level of skill (Chitechi, 2011). 
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2.1.2 Continual Improvement theory 
Continual improvement, a term of art coined by Clayton (2005), describes a process by 
which a product or service takes root initially in simple applications at the bottom of a 
market and then relentlessly moves up market, eventually displacing established 
competitors. Disruptive innovation describes a process by which a product or service 
takes root initially in simple applications at the bottom of a market and then tent 
relentlessly moves ‘up market’, eventually displacing established competitors.  
 
An innovation that is disruptive allows a whole new population of consumer’s access to a 
product or service that was historically only accessible to consumers with a lot of money 
or a lot of skill. Characteristics of disruptive businesses, at least in their initial stages, can 
include: lower gross margins, smaller target markets, and simpler products and services 
that may not appear as attractive as existing solutions when compared against traditional 
performance metrics. Companies tend to innovate products that their consumers need, 
with a hope that their lives change. By only pursuing sustaining innovations that 
perpetuate what has historically helped them succeed, companies unwittingly open the 
door to “disruptive innovations” which are ways that go beyond the general direct 
expectations of consumers (Bitrix, 2007).  
 
Companies pursue these “sustaining innovations” at the higher tiers of their markets 
because this is what has historically helped them succeed: by charging the highest prices 
to their most demanding and sophisticated customers at the top of the market, companies 
will achieve the greatest profitability. However, by doing so, companies unwittingly open 
the door to “disruptive innovations” at the bottom of the market. An innovation that is 
disruptive allows a whole new population of consumers at the bottom of a market access 
to a product or service that was historically only accessible to consumers with a lot of 
money or a lot of skill (Bitrix, 2007). 
 
Characteristics of disruptive businesses, at least in their initial stages, can lead to 
companies tending to innovate faster than their customers’ needs evolve, most 
organizations eventually end up producing products or services that are actually too 
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sophisticated, too expensive, and too complicated for many customers in their market and 
eventually the expectations of the consumers as stated by Lee et al., (2012) in his study 
on the rapid increase of manufacture of new car models by Toyota.  
 
2.1.3 Vroom's expectancy theory 
Developed in 1964, the Expectancy Theory of Motivation was created by Vroom. This 
theory assumes that behavior results from conscious choices among alternatives whose 
purpose it is to maximize pleasure and to minimize pain. Vroom realized that an 
employee's performance is based on individual factors such as personality, skills, 
knowledge, experience and abilities. Effort, performance and motivation are linked in a 
person's motivation, and use the variables Expectancy, Instrumentality and Valence to 
account for this, (Huerta et al., 2008).  
 
Expectancy is the belief that increased effort will lead to increased performance i.e. if I 
work harder than this will be better. This is affected by such things as, having the right 
resources available (e.g. raw materials, time), having the right skills to do the job, and 
having the necessary support to get the job done (e.g. supervisor support, or correct 
information on the job). Instrumentality is the belief that if you perform well that a valued 
outcome will be received. The degree to which a first level outcome will lead to the 
second level outcome. I.e. if I do a good job, there is something in it for me. This is 
affected by such things as: clear understanding of the relationship between performance 
and outcomes; trust in the people who will take the decisions on who gets what outcome 
and transparency of the process that decides who gets what outcome. Valence is the 
importance that the individual places upon the expected outcome. For the valence to be 
positive, the person must prefer attaining the outcome to not attaining it. For example, if 
someone is mainly motivated by money, he or she might not value offers of additional 
time off, (Huerta et al., 2008). 
 
When applying expectancy theory to a workplace setting it’s important to keep a few 
things in mind. The first is that management needs to establish clear linkages between 
effort and performance, as well as performance and outcomes. Not doing so can 
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inadvertently impact performance on the job as employees are lead to believe their 
increased effort provides little benefit. The second is that management needs to focus on 
providing desirable outcomes to employees. Many times employers offer the same type 
of rewards to all employees. This is one of the most significant errors in motivation 
because one thing rarely motivates employees to the same degree. The reward itself isn’t 
the point, the point is that it means something to someone else and will thus impact their 
behavior hence motivating them to work even harder, in the end the employer gains 
(Huerta et al., 2008). 
 
2.2 Empirical Literature Review 
2.2.1 ICT Usage and Pharmaceutical marketing 
Escalating costs, increasing  complexity and a dwindling population of drug candidates 
suggest that traditional methods are unlikely to produce enough breakthrough drugs to 
ensure growth. In drug manufacturing, and eventual reach to the consumer, increasing 
inputs leads to an approximately proportional increase in outputs, and many go in 
between, lead to high uptake, or low uptake of the drugs thus increasing or decreasing 
economies of scale of manufacture. ICTs marketing offer the greatest value for 
pharmaceutical companies when they are paired with the scientific advances, 
revolutionizing drug discovery, and consumer needs (Kable, 2013). 
 
Lewis, (2007) suggest that genomics, bioinformatics, and advances in drug discovery 
technologies unleash the power of innovation by greatly increasing the number of new 
drug targets and chemical compounds, as well as accelerating the speed with which they 
can be matched, he however notes that the gap between the manufacture of the drug, and 
the consumer of the drug, a gap that can be bridged by use of ICT by marketing 
representatives who work between manufactures and consumers. ICTs provide the tools 
to harness and navigate the flood of data, identify promising prospects for targets and 
compounds, and assess which are most likely to produce results. 
 
Tollerman (2001) suggested that looking at the impact of ICTs on healthcare reveals an 
enormous range of opportunities for significant corporation and service enhancements, 
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aimed at improving health of the consumer. In so doing it focuses upon applications in 
four key areas. Payer applications–this includes management of funding and delivery 
programs, by all health providers and use of commerce and electronic communication to 
coordinate healthcare organizations and activities throughout the system to ensure that 
funds are transferred all across the health providers; Provider applications- includes 
applications of health in ensuring that the provider has all the necessary applications to 
provide for the best health care, from the manufacturer to the consumer. Practitioner 
applications – this is adoption of practice management tools, clinical tools and 
communication systems that ensures the practitioner has all the tools to practice health 
administration, and Patient applications- new forms and locations of care delivery, the 
emergence of informed consumers and of new information and health intermediaries, and 
the ability to use this information appropriately.  
 
The endowment with ICT has by now reached a level that allows investigating possible 
effects of ICT use on various dimensions of the performance the pharmaceutical field. It 
makes a twofold contribution in this direction: It investigates empirically the impact of 
ICT on product and process innovation in drug manufacture, and, with the use of specific 
ICT applications to ensure standards within the industry. The interface between the 
pharmaceutical industry and the healthcare industry is being changed by ICT 
applications, with many opportunities for cost savings and efficiency gains. In the 
pharmaceuticals industry there is a convergence of leading-edge information and bio-
technologies which looks set to transform the drug development pipeline. The demand 
for new biotechnology and informatics capabilities within established pharmaceutical 
companies, and the emergence of new players into the industry with specialist skills in 
biotechnology and/or informatics, experience in using bioinformatics in genomics and 
genetics, and much sort after proprietary databases presents many new challenges (Tuner, 
2010). 
 
ICT and production present both threats and opportunities for pharmaceutical industry 
development, with changes in core skills likely to affect the relative attractiveness of 
different locations, the viability and the mobility of investment within the industry.  The 
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potential for pharmaceuticals manufacturers and suppliers to integrate more fully into 
clinical systems opens up enormous possibilities (and risks) in terms of influencing drug 
selection and usage at the critical point of care. (Kable, 2013).  The critical barrier facing 
pharmaceutical companies in navigating these possibilities and realizing potential 
opportunities appears to be that of maintaining credibility while gaining advantage in the 
process of manufacture of drugs.  
 
The use of ICT supports and contributes to innovation activities through three main 
channels. The first channel goes through the improvement of the management of the data 
and knowledge used in the innovation process. These data and knowledge might be 
internally created or externally acquired. ICT enables an efficient storage and a high 
accessibility of these data and knowledge throughout an enterprise in a coordinated 
manner. Second, ICT enables a more efficient cooperation in innovation with external 
partners. The creation of new knowledge through collaboration with other firms has 
become more and more important in the last twenty years (Enkel, 2009).  
 
Information technology facilitates the exchange of information with external partners that 
are located far away from the focal firm. Third, ICT contributes directly to the innovation 
production in several ways. Identified three main stages of the innovation process, for 
which the application of ICT has proved to be useful. First, the stage of the generation of 
ideas for new products can benefit from information systems that enable a firm to analyze 
customer’s communication and transaction data and identify needs that can be covered by 
new products or significant modifications of existing products. Further, ICT enables the 
development of efficient design capabilities for new products (Cutler, 2005). 
 
2.2.2 Education on pharmaceutical products and employee performance 
The link between education investments and productivity within the work place is rather 
indirect, and positive effects are contingent upon additional complementary investments 
into innovation and human capital at the firm level.  The empirical evidence suggests that 
innovative firms are more likely to exhibit productivity increases staff knowledge on key 
products to enhance development. More advanced product users are more likely to 
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experience productivity gains and be highly motivated by their performance. These 
results suggest that intense product training combined with innovate activity are 
positively related to productivity growth at the firm level(Jefferson, 2005). 
 
It is noted by Koellinger, 2005) that the key to understanding the impacts on performance 
is to view product education as an enabler of innovation and thus performance. This 
conceptualization of new technologies as a possible enabler of innovation allows a 
market-based approach to study the relationship between product knowledge and 
performance. Management literature recognizes numerous concepts and variables to 
measure performance. Profits, sales, market share, productivity, debt ratios and stock 
prices. Many of these different measures are correlated since they function in similar 
environment. Which of the measures is given priority is essentially a matter of 
perspective management; however, as employees and stakeholders are likely emphasize 
different performance measures as most relevant to them.  
 
The effects of product education on corporate performance are subject to debate because 
not all studies have demonstrated clear payoffs from these investments. Also, the results 
vary depending on how performance and payoffs are measured and analyzed. On the 
conceptual level, say there exists a clear link between product knowledge and innovation 
to enable better performance. E-business and ICT investments can only increase with 
knowledge of product in general; it can enable process innovations in marketing (Enkel, 
2009).  
 
Whether the increasing product knowledge creates or destroys jobs remains a subject of 
debate. Theory suggests that the net impact depends on the relative strength of two 
competing effects: On the one hand, this state can lead to innovations which can result in 
output growth and a concomitant growth in jobs. On the other hand, process innovation 
productivity gains imply that a given output level can be produced with less labour input 
putting the manufacturer at competition with itself. Adopting market-based, economic 
perspective, possible consequences of this approach in three different, although related 
areas: (1)corporate performance, empirically measured by turnover development, (2) 
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productivity and (3) employment dynamics. Based on a literature review of recent 
research findings by Kleis, (2010). 
 
The same results offered by Black and Lynch (2001), who examined the impact of 
product training on pharmaceutical staff state that it increases confidence in the staff 
marketing the medicine. Product Management training in Developing and Developed 
Countries in the medical field for marketing staff. The relationships between productivity 
growths, evidence of the positive impact of complementarities in a comparative study.  
The study found a positive correlation. Evidence of the positive relations of improved 
human capital and organizational horizontal growth in their study on organizational 
accredited training.  
 
2.2.3 Age of Medical Representative and Employee Performance 
ICT usage and its different applicability have been defined by different scholars in 
various ways. Many definitions focus particularly on the ‘newer’ computer-assisted, 
digital or electronic technologies, such as the internet of mobile telephony and the current 
generation referred to as generation. E-health is the use of emerging information and 
communication technology, especially the Internet, to improve or enable health and 
healthcare. This term bridges both the clinical and non-clinical sectors and includes 
equally individual and population health-oriented tools (Waldburger, 2004). 
 
Advances in ICT in the last quarter of the 20thcentury have led to the ability to more 
accurately profile individual health risk. To understand better basic physiologic and 
pathologic processes and to revolutionize diagnosis through new imaging and scanning 
technologies human resource that can articulate and interpret such information is 
required. Hence, such technological development, demands an increased responsibility of 
practitioners, managers, and policy-makers for assessing the appropriateness of new 
technologies and protecting records to ensure they match the patient and the diagnosis 
(Eysenbach, 2008).  
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The age of medical representatives and ICT usage has in the last decade been extensively 
proposed as a means to reform, modernize and even reshape national health systems and 
has direct effect on their performance. Adoption of such market based systems is 
expected to achieve cost effectiveness, support clinical decision making, improve 
patients’ privacy and safety, speed-up delivery and improve the quality of healthcare. 
Adopting technology is however not without consequences; market based systems 
challenge health professionals’ work practices, the roles they occupy, the types of 
knowledge they use and the modes of collaboration they employ, thus need for policy and 
regulation. It is the rate, attitude and ability of adaptation to technology that is key and 
not the age of the nurse (Muneer, 1999).  
 
Professionalism in institutional settings is influenced by specific standards, code of ethics 
and behavioral norms drawn from the profession but also, to degrees, from their 
employing organizations there is an impact of age of the performers.  A re-look at the age 
of those conducting the work setting promotes changes to work practices, roles and 
identities. Typically age to gather, maintain, process and disseminate cuts across temporal 
and spatial boundaries within the operations of the company (Muneer, 1999). 
 
Friedman (2002) has shown that organizations managed care demanded more, not less, 
marketing effort, and more complex, not simpler, management structure. As the field 
force has remained the most potent and expensive instruments of the pharmaceutical 
company, it is essential that investment in this tool be optimized, and properly utilized. 
Tried to emphasize the influence of age policies on both doctors and pharmacist toward 
the use of generic drugs in Jordan. He studied the influence of age policy of practitioners 
on the performance of doctors and toward prescribing new generic products to their 
patients. Results provided clear support for older doctors and their belief on original 
drugs.  
 
2.2.4 Public Perceptions factors in the pharmaceuticals industry 
According to Jones (2000) the success or failure of a business to a great extent is 
influenced by consumer perception. Though a consumer’s perception about a product or 
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service to some extent is said to be based on his or her actual experience obtained from 
the use of specific goods or service, it is also to a great extent influenced by a variety of 
other factors such as price, quality, and reputation of the manufacturer, branding, and 
packaging including other complex psychological factors. Patient satisfaction is an 
important measure of how well services are provided, and the ability for a drug to cure or 
offer some relief is key in pharmaceutical marketing. 
 
Pricing of pharmaceutical products has a key effect on consumer perception. Though a 
large majority of consumers appreciate and favor a low or reasonably priced item, there 
are also cross sections of sophisticated and skeptical consumers who look down up a 
product that is considerably low priced than the other available alternatives or generics. 
They are considered below standard and not fit for human consumption. Many such 
consumers tag the product as cheap hence pricing of a product or service should form the 
basis of a larger marketing plan. By doing so, even low priced products can be marketed 
as favorable ones with good quality and at a better price, however, in the study of tropical 
over the counter medicine. Most consumers preferred to use cheap antibiotics as opposed 
to expensive ones due to the thought that the cheap ones do not easily reach resistance 
levels (Kohler, 2007).  
 
The importance of the quality of a product or service from the perception of a consumer 
can never be undermined. Any feature of the product such as its use, durability and how 
reliable the product is in satisfying or disappointing the consumer can be described as its 
quality. Pharmaceutical marketing to a great extent helps in influencing the consumer’s 
perception about the quality of product but even word of mouth communication about 
quality of a product is equally effective and travels fast. Though marketing plays a 
greater role in influencing the consumer’s opinion about quality of a product, it is the 
consumer’s inherent opinion from the use of a specific product or service that will 
determine the awareness about quality. As much as performance of the drug includes a 
myriad of factors, consumers’ perception on a particular drug outweighs it performance, 
and actually it is the drug name that sell, not the drug (Troy, 2000). 
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Bell, (2007) states that the first impression is the best impression very aptly applies to 
consumer perception of pharmaceutical product especially at the time purchase. How a 
product is attractively packaged to exhibit the display quality by the manufacturer 
determines the perception of the product. Even branding messages for drugs that cure 
chronic disease need to be friends, and stabile, and moreover, as reliable, long lasting, 
tough are of great help in promoting the product perception. 
 
History and reputation of a company and its products and services plays an equally 
important role in the consumer perception. Age old businesses with strong reputation and 
history are always preferred by consumers whereas new products are always tried with 
caution and based on public opinion and reviews, especially to the older generations, and 
those who have used their services before (Bell, 2007).   
 
Online as well as offline reputation of a company and products and services largely 
influence the consumer perception. Any negative reviews and opinions online or by word 
of mouth can strongly affect the overall performance of pharmaceutical companies, and 
they try to guard their reputations. In his scholarly work on lethal drugs, used for 
execution in various USA states found that this stance does not hold, for such companies, 
they hid their identity and only promote the efficacy of “the killer drug”. Only the 
socially perceived positives sell, within this industry, and companies will try to keep the 
persons associated with the good, and not those associated with the bad.  “ If any product 
has not performed well in the past or if any company has been alleged for any 
unscrupulous activity will strongly affects its performance for long period of time, and it 
will be gotten off the shelf, rebranded, or its composition changed, since these are matters 
of human health (Marks, 2010). 
 
2.3Summary and Research Gaps 
Medical representatives are the bridge between the drug producers, and the drug 
consumers. The marketing aspect of medical representatives ensures that the practitioners 
are aware of the current drug in the market, while at the same time, the producer of the 
drug knows which drug needs production. Scholarly work seems not to have explored 
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much information in relation to the impact of marketing of the drugs, and how ICT has 
enhanced this important aspect. Payer applications, Provider applications, Practitioner 
applications and Patient applications have not been integrated to form a seamless 
transaction that ensures health benefits to the end user. 
 
Further research gaps that focus on whether age of medical representative  influence their 
performance in the conquest of marketing pharmaceutical goods has also not been fully 
explored. The age of the medical representatives has a correlation to the level of 
experience the medical representatives be it in terms of consumption of pharmaceutical 
products, or marketing of the pharmaceutical products. The age of the med rep further 
influences their performance in terms of reach, and accessibility of the products.  
 
There seems to be a gap in defining the appropriate training of medical representatives; 
this borders on whether to concentrate their training to be inclined on biochemical 
knowledge so as to enable them be at a position to understand drug composition, thus 
explaining their efficacy, while on the other hand, a training, that is inclined on marketing 
so as to enhance the spread of the pharmaceutical products. There seems to be a scholarly 
gap regarding this issue, a fact that Dawa pharmaceuticals bridges by conducting on job 
training for its employees.  
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2.4 Conceptual framework 
Figure 2.1 Diagram depicting the relationship between theory(s) independent and 
dependent variables 
Independent Variables  Dependent variables 
 
 
 
 
 
 
 
 
 
 
 
2.5 Operationalization of variables 
2.5.1 ICT usage 
ICT has changed and transformed how the world thinks and performance. ICT has 
revolutionized health care and is responsible for the current on spot diagnosis and 
treatment of diseases. The effect use of ICT as a form of communication within the 
pharmaceuticals industry enables improvement of product manufacture and produce 
utilization. ICT usage offers a dual effect in this perspective 
 
2.5.2 Education on Pharmaceutical products 
Pharmaceutical product knowledge, sales planning, innovation and information about the 
product increases the medical representative’s confidence while marketing and provides 
them with a platform to advice consumers from an informed platform. This variable also 
helps to effective information on the market dynamics and efficacy of pharmaceutical 
products. 
 
 
Vroom’s theory of 
expectancy 
Public perception 
Continual Improvement 
theory 
Hygiene Motivation 
theory 
Performance of 
Medical 
representatives 
Training of medical reps 
Age of medical reps 
ICT usage 
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2.5.3 Age of medical representative 
Age denotes wisdom and experience; however this is not applicable in the medical realm 
as noted by Waldburger, (2004) in their study on challenges of working with old 
professionals in the transport industry. Most healthcare equipment is ICT dependent, and 
the ability to use them is reliant on the professional’s ability to learn and conceptualize 
the ICT functionalities.  
 
2.5.4 Public perception 
How the market perceives a product influences their attitude towards the product, 
regardless of the efficacy of the product. This is in regardless to inferiority or simply an 
inability to communicate properly by the medical representative or the packaging of the 
product (Cooper, 2004). This study also will try to find out if perceived poor attitude of 
old pharmaceutical companies is as a barrier to health care access. 
 
2.6 Chapter summary  
This chapter looked at other scholarly work regarding use of ICT in pharmaceutical 
marketing, and its importance in this realm. Various theories that support its use, 
challenges and the areas not yet explored. Further, this chapter looked and different 
studies on how these have work in various industries.  The chapter ends by stating the 
knowledge gaps encountered.  
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CHAPTER THREE 
RESEARCH DESIGN AND METHODOLOGY 
3.0 Introduction 
This chapter presents the research methodology used in conducting the study describing 
the research design, location of the study, target population, sampling procedures, 
sampling size, instrumentation, data collection and analysis procedures employed. 
 
3.1 Research Design 
Research designs refer to the plan on how to answer a research question. It refers to the 
overall strategy chosen to integrate the different components of the study in a coherent 
and logical way, thereby, ensuring effectively addressing the research problem; it 
constitutes the blueprint for the collection, measurement, and analysis of data. Research 
designs Is arrangement of conditions for collecting, an analyzing of data in a manner 
aimed to combine relevant research purpose with economy if procedure.  According to 
Kothari (2006), a research design is the collection and arrangement of conditions of 
analysis of data in a manner that aims to combine relevance to the research purpose with 
economy in procedure. In this case both quantitative and qualitative research designs 
were used.  
 
3.2 Target Population 
Mugenda and Mugenda (2003) describes target population as a complete set of 
individuals cases object with the same common characteristics to which researchers want 
to generalize the results of the study. Population is the targeted group, that is, the groups 
about which the researcher is interested in getting the information from and drawing 
conclusions.  Senior managers from insurance companies are directly involved in strategy 
formulation and implementation within organizations. This study employed three types of 
population;  the medical representatives, these were the pharmaceutical marketing staff 
employed by Dawa Pharmaceuticals, who have connections between the drug producers, 
the drug  producers, who are responsible for production of the drugs, and the consumers, 
in this case the chemist owners, who prescribe the drugs to their customers. 
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Table 3.1 Showing target population 
Category   Number 
Medical Representatives  400 
Chemists  300 
Line Biochemists 36 
  
Total 1236 
 
 
3.3 Sample and sampling technique 
A sample is a sub-group drawn from the target population with relevant characteristics. 
According to Kothari (2006), where it is not always appropriate or possible to study the 
whole population, a sample may be drawn. Sampling is a process of selecting a number 
of individuals for a study in such a way that individuals selected will represent the target 
group from which they will be selected. Sampling procedures are the definite plans of 
obtaining a sample from a given population.  They inform the size of the population in 
consideration. The researcher considered definite and indefinite types of population, the 
sampling unit based on social and physical factors, the acceptable levels of the sample 
sizes, available resources, and the parameters of interest.  Data for this study were be 
obtained the human resource department of Dawa pharmaceuticals. 
 
In practice, the sample size used in this study was based on the expense of data 
collection, and the need to have sufficient statistical power. In addition to the purpose of 
the study and population size, three criteria employed were the level of precision, the 
level of confidence or risk, and the degree of variability in the attributes being measured 
(Kothari, 2006). 
 
In determining the appropriate sample, Fischers’ formula n = z2pq/d2 was used as 
quoted in Mugenda and Mugenda, (2003). Where; n is desired sample size, z is the 
standard normal deviate at the 95% confidence level, p is the proportion in the target 
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population estimated to have the characteristics being measured, in this case, p is 0.5, q is 
1  and p is 0.5. d is the marginal error of 5%.  
 
 Probability sampling method of simple random was then applied in selecting the specific 
populations for the study, application of Fischer’s formula used to get the desired sample 
size. From each group, 30% of the population was selected using simple random 
sampling to deduce the medical representatives and chemists for the study. purposive 
sampling was used to selecting biochemists 
 
Table 3. 1: Table Showing Research Study Sample Size 
Category   Number % of the total Sample size (30% of 
population 
Medical 
Representatives 
 150 45% 75 
Chemists  100 40% 60 
Line Biochemists 9 15% 5 
Total 359 100% 140 
 
3.4   Data Collection Methods 
Data was collected using self-administered questionnaires to ensure the respondents have 
a sense of confidentiality with no fear of victimization.  The questionnaire had both 
structured and unstructured questions. Structured questions were accompanied by a list of 
all possible alternatives or options from which the respondents selected the answer that 
best describes their situation. The unstructured questions gave the respondent complete 
freedom of responding. Questions were formulated in English. 
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3.5 Pilot Test 
3.5.1 Validity Test 
According to Wallen (2000), validity relates to the quality attributed to the degree to 
which they conform to establish knowledge or truth.  It refers to the extent to which an 
instrument can measure, or, ought to have measured. It is the accuracy and 
meaningfulness which are based on the research results. Concurrent Validity refers to a 
measurement device’s ability to vary directly with a measure of the same construct or 
indirectly with a measure of an opposite construct.  It allows showing that the test is valid 
by comparing it with an already valid test.  Content validity is concerned with a test’s 
ability to include or represent all of the content of a particular construct. In order for a test 
to be a valid screening device for some future behavior, it must have predictive validity.  
The study conducted a pilot test, to the content validity of the tools and their ability to test 
the desired variables.  
 
3.5.2 Reliability Tests 
Wallen (2000), states that reliability indicates the extent to which a measure is free from 
random error. Random error occurs when effectiveness of measured variable is 
influenced by other factors besides conceptual factors of interest besides the main 
variable .A pilot test totaling to 18 medical representatives, and 5 chemists operators who 
were randomly selected were used in the pilot test.  The pilot test tested the ability of the 
questions to measure the desired concept, the degree of accuracy of the measuring tools, 
and the researcher’s interpretation of data.  This exercise helped refine the tools more for 
accuracy and was done two weeks before the real data collection period.   This test was 
conducted twice, to ascertain its reliability. 
 
3.6 Data Analysis Methods 
Since the instrument of choice for this research is a semi-structured questionnaire, data 
analysis was composed of both quantitative and qualitative analysis. The quantitative 
analysis was done to establish the measures of central tendency that included the mean, 
mode, and median highlighting the key findings. The quantitative data was edited and 
coded into Statistical Package for Social Sciences (SPSS) for analysis. The qualitative 
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data was analyzed by means of content analysis. This process uses inductive reasoning, 
by which themes and categories emerge from the data through the researcher’s show 
careful examination and constant comparison (Patton 2002).  
 
3.7 Data Presentation 
Presentations of analyzed data inform of qualitative and quantitative formats were 
considered. Measures of variation, and tendencies of standard deviation, and other data 
were presented in bar graphs, histograms, tables, and pie charts. There was also 
qualitative presentations informs of direct quotation and pictures from the respondents.  
 
3.8 Ethical Considerations 
This study involved human subjects, thus ethical considerations were highly considered.  
Wallen (2000) defines ethics in research the ability of a researcher to report exactly what 
happened. It involves maintaining honesty in conducting and reporting scientific research 
and credit for ideas and efforts. Treating research participants ethically matters not only 
for welfare of individuals but for continued effectiveness of behavioral science as a 
scientific discipline. 
 
3.8.1 Confidentiality and Privacy  
There was respecting privacy of participants by assigning them unique identifier codes to 
protect their identity and the responses that will have given. The study generalized the 
finding, thus information could not be associated to an individual. In addition, other 
practices, such as changing the reported characteristics of participants such as gender was 
also used by some to conceal identities and thereby maintain the confidentiality of the 
data provided by participants.  
 
3.8.2 Anonymity  
Anonymity, according to Mugenda and Mugenda (2003) only occurs if identity of 
participants is central to ethical research. Where possible, researchers aim to assure 
participants that every effort is made to ensure that the data they provide cannot be traced 
back to them in reports, presentations and other forms of dissemination.  Before 
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conducting the research and in accordance with social research protocols, the identity and 
research time, were protected. The study assigned unique identifies for the respondents, 
the use of pseudonyms for participants and also for the location of the research.  
 
3.8.3 Power Balance 
Mugenda and Mugenda (2003) in his scholarly work states that power balance in research 
is essential in ensuring that the quality of research is guaranteed.  Maintaining awareness 
of power difference between the researcher, and the respondents was observed by 
avoiding abuse of power on junior staff, by not showing up late for the appointments 
during the interviews, and by not promising money to sway the research. 
 
3.8.4 Informed consent 
Participants were informed and their consent sought for use for the purpose of the study.  
The informed consent included; expected duration of research, and right of participants to 
decline or withdraw during the process. 
 
3.9 Chapter Summary 
This chapter has discussed the methodology that was used in the study, it has critically 
analyzed the research design, target population, the sample design, data collection 
techniques, validly and reliability test and the application package for data analysis.  
 
 
 
 
 
 
 
 
33 
 
CHAPTER FOUR 
DATA ANALYSIS, RESULTS AND DISCUSSIONS 
4.0 Introduction 
This chapter presents the findings of the study, which was to determine the factors 
affecting the performance of medical representatives. The chapter has been sectioned 
into; response rate, response demographics, an evaluation of the effect of ICT usage on 
performance of medical representatives, an establishment of the effect of education of 
pharmaceutical products  on performance of medical representatives, a determination of 
the effect of age on the performance of medical representatives and an examination of the 
effect of public  perception on pharmaceutical products on performance of medical 
representatives at Dawa Pharmaceuticals Company in Nairobi 
 
4.1 Response rate 
The study sought to reach 60 medical representatives, 45 chemist owners, and 5 bio 
chemists.  Factors such as their availabilities, commitment to responding and acceptance 
to participate in the research were considered during the study.  Fig 4.1 shows the study 
response rate.  
 
Fig: 4.1 showing study response rate 
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The study interviewed 98% of the intended medical representatives, 80% of the intended 
chemists, and 80% of the intended bio chemists.  As stated by Mugenda and Mugenda 
(2003) regarding target population reach for social studies, this study attained an average 
reach of 75% of the intended population. 
 
4.2 Respondents demographic 
The Socio economic demographics of respondents aid researchers in knowing the 
background of respondents. The study sought to find out the gender, age brackets, marital 
status and education levels of the responds.  
 
Demographic 
factors 
 Medical 
representatives 
Chemist 
Owners 
Bio 
Chemists 
% of Total 
Gender Male 36 31 2 66 
Female 24 9 1 34 
Age brackets 20-30 yrs 43 9 0 49 
30-40 yrs 10 12 1 21 
Above 
40yrs 
7 19 2 30 
Marital status Single 15 0 0 15 
Married 45 40 3 85 
Highest 
Education 
level attained 
Secondary 10 5 0 15 
Bachelors 39 33 0 60 
Post 
Bachelors 
11 2 3 15 
 
The research carried out,66% of the respondents were male, 49% of the respondents were 
between the ages of 20 and 30 years old.  Most of the respondents were married (85%) 
and only 15% of the respondents had a post bachelor’s education. Further probe into the 
data revealed that most of the married medical representatives were male, proving the 
fact that their job requires a lot of traveling away from family thus not suitable for most 
females who were settling down to starting or nurturing their families.  
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The study further, under demographics sought to find out how long medical 
representatives had worked in the particular company.  84% of the medical 
representatives who were within the age bracket of 20-30 years reported as being below 
one year, 10% who were between the ages of 30-40years as having worked for between 
one to five years,  while 5% were above the 40years mark had worked for periods above 
five years. The study interpreted this finding to having an angle towards job stability and 
security of the employees, a fact that affirms the Motivation-Hygiene Theory by 
Herzberg, et al., (1998) where employees continue looking for factors that sanitize their 
work. As employees got older, they stabilized in their employment stations, while 
younger ones kept looking for greener pastures. 
 
4.3 ICT usage 
The study sought to find out the level of ICT usage amongst the medical representatives. 
This question would help the study determine the level of ICT influence in their 
performance. The ICT usage was limited to usage of smart phones to communicate 
during working period, usage of emails between themselves and other departments within 
the organizations, and use of faxes, and emails in communicating between them and their 
clients. The same question was also asked to bio chemists, and chemist owners.  The aim 
of the question was to establish to what level ICT usage influenced their work as 
individuals and what they felt about ICT usage at Dawa. The findings of this objective is 
presented in figure 4.3 below.  
 
Fig: 4.3 showing ICT usage amongst respondents 
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The study found out that 40% of the medical reps moderately use ICT in the course of 
their work, 25% of chemist owners highly use ICT in their work, and all the bio chemists 
interviewed during this study used ICT in their work. The respondents affirmed that ICT 
was key in determining their performance, however as one medical representative 
asserts;“ICT is important in this era, both at individual level and organizational level. The 
company needs to put in place systems that are integrated and those that operate through 
similar platforms, this I mean from procurement, to manufacture and feedback from the 
field. The current situation is that there is some form of ICT, though in silos, each 
department communicates on its own, yet to outsiders we are one organization and should 
be integrated, I believe this will have an overall performance even at organizational 
level”.  
 
Further investigation into the usage of ICT exposed that there was a relationship to age of 
the respondents. Younger respondents used ICT in most of their transactions; this case 
was not similar to the older category of those above the ages of 40years. Under the usage 
of ICT, the study also did find out that most male’s medical representatives, within the 20 
– 30 years age bracket were more technology savvy than their female counterparts. The 
scope of the study did not however investigate reasons as to why the disparity.  
 
The chemist owners and bio chemists relied heavily on ICT in conducting their business, 
and communicating within and outside their organizations. The chemists’ owners used 
ICT in their procurement and sales processes.  The bio chemists used ICT in getting the 
chemical formula for the pharmaceutical products. The bio chemists interviewed 
however, did not have any form of communication pertaining their work with the medical 
representatives, and according to them, there was no way their usage of ICT by medical 
representatives affected their performance. They however felt that there was need for an 
integrated system, to offer them a platform to measure and evaluate their work.  
 
4.4 Products Education 
The study sought to find out what form of education was important and relevant to the 
respondents with a view of improving their performance.  There is limited literature on 
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what form of training would be preferred for medical representatives, the measure of 
medical representatives cannot be complete without measure of utilization of the drug. 
Education for medical representatives enables them markets the drug, and its utilizations, 
to their clients, who prescribe, and dispense the drugs. If the drug is not well marketed, its 
utilization is compromised. The findings of this study show what form of education the 
medical representatives preferred more education on ( fig 4.3.1), the findings chemist 
owners felt the medical representatives should have education on, (fig 4.3.2) and the 
findings bio chemist felt, medical representatives should have education on, (fig 4.3.3).  
 
Objective 2i; Type of training preferred by medical representatives 
Fig 4.4.1 Showing education preferences by medical representatives 
 
 
From the Research, 45% of medical representatives felt that they need more education in 
the realm of pharmaceutical products, 35% felt they needed education in marketing, 
while 20% felt they need more education on both pharmaceuticals and marketing. This 
data was further scrutinized and compared to their corresponding demographics, the 
results were such that, 75% of those who felt that they needed more education on 
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pharmaceutical were within the age brackets of 30years to 40 years, and 60% of those 
requiring education on marketing were within the age brackets of 20-30years. Those who 
opted for education in both marketing and pharmaceutical knowledge were above the age 
of 40 years old. This finding alludes to the fact that those above the age of 40 years were 
settled in their professions and were determined in improving their performance by 
enhancing their skills 
 
Objective 2 ii: Type of training preferred for medical representatives by chemists 
Fig 4.4.2 showing education preferences for medical representatives by chemist 
owners 
 
 
From the study,65% of the chemist owners felt that medical representatives required 
more education on matters related to pharmaceutical products, 20% felt they needed 
education on marketing and 20% felt education on both marketing and pharmaceutical 
products would enhance their work. Chemists mostly dispense drugs to patients, thus 
making them persons who are go between the company representative and the patients. 
The performance of pharmaceutical industry is dependent on its ability to efficiently and 
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effectively communicate. Chemists training is generally biased towards pharmaceuticals 
products, their ability to communicate to medical representatives who are more included 
towards marketing the right drug with appropriate composition is key to them 
 
Objective 2 iii: Type of training preferred for medical representatives by bio 
chemists 
Fig 4.4.3 showing education preferences for medical representatives by bio chemists 
 
 
The Study also shows41% of biochemists would prefer medical representatives to have 
an education on etiological trends, and 14% of them felt that education on 
communication would enhance their work.  These findings indicate that most bio 
chemists would like to manufacture drugs that respond to the societal needs; however 
they lack information on the efficacy, and performance of their productions.  The finds 
further affirm an earlier knowledge gap at Dawa on silos communication, a situation that 
requires harmonization to enable combined organizational performance.  
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4.5 Age of Medical representative 
The study sought to establish whether the ages of medical representatives had an effect 
on their performance. The age of medical representatives did not directly influence 
performance; however, it did influence their performances. According to this scholar, 
compounding age factors such as marital status, health, experience, and expectations that 
are directly related to a medical representatives age, does have an influence on 
performance.   
 
Outputs are immediate effects and their measure assumes a quantitative angel, while 
outcomes are long term effects and their measure does assume a qualitative angle. This 
study was interested in finding out whether age affected their performance in terms of 
their output and outcomes. The question was asked to chemist owners had the following 
findings as depicted in the table below 
 
Age bracket Performance Output Performance Outcome 
20 – 30 years high low 
30 – 40 years medium medium 
Above 40 years low high 
 
When delved further regarding the indicators of outputs and outcomes relating to 
performance of chemists in relation to their interactions with medical representatives, one 
chemist owner reported;“Younger medical representative’s aim is to push the drug into 
the market, regardless of its performance, cost and even knowledge of its composition. 
Older medical representatives are better, especially when they are marketing drugs that 
are designs for older populations. The older ones take time, to understand the 
performance of the drug, and even offer after sales service to find out about their 
performance. If performance is measured in terms of quantity of products in the markets, 
then those in the younger category would be seen as good performance, however, if 
performance is measured in terms of quality, then the older generation performance far 
outweighs that of the younger medical representatives”.  
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4.6 Public perception 
The study sought to know whether public perception does influence the performance of 
medical representatives.  The figure below shows the findings of this study. 
 
Fig: 4.5.1 showing relationship between public perception and medical 
representative’s performance. 
 
 
From the study, 60% of respondents felt that the public perception of the pharmaceutical 
company influenced its performance, 30% felt this ratio was moderate, while only 10% 
of the respondents felt that the pharmaceutical company’s perception did not affect the 
performance of medical representative. The public perception and attitudes toward 
leading companies do not always reflect attitudes toward the industry.  Leading 
pharmaceutical companies tend to be better perceived when it comes to the quality of 
their products and their industry leadership than on being good citizens. The study further 
sought to establish what led the public to develop such attitudes towards local companies.  
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Fig: 4.5.2   Showing public perception local pharmaceutical products. 
 
 
4.7 Chapter summary 
Chapter  four  of the report  covers response rate, response demographics ,effects  of  ICT 
usage on the performance of medical representatives ,effects of age on the performance  
of medical representative , and the effect of public perception on the performance of  
medical representative at  Dawa pharmaceutical. 
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CHAPTER FIVE 
SUMMARY OF FINDINGS, RECOMMENDATIONS AND CONCLUSION 
5.0 Introduction 
This chapter presents a summary of the findings, as regards to the main objectives of the 
study. Based on these findings the conclusions were drawn and some recommendations 
on the way forward made.  
 
5.1 Summary of Findings 
The study found out that the usage of ICT had a positive effect on the performance of 
medical representatives at Dawa Pharmaceuticals Company. ICT enabled internal and 
external communication, making it easier for decision making and follow up. The study 
also found the younger male medical representatives used a lot of ICT in performance of 
their work as compared to their female counterparts. This study also did find out that 
communication at Dawa is in silos, and departments did not know what goes on in the 
other department, a situation that negatively impacts on the performance of medical 
representatives. 
 
The second study objective was to establish whether education on products did affect 
performance of medical representatives. The findings of this study were that education on 
medical products did affect the performance of medical representatives. The more a 
medical representative understood the products, in terms of its composition and usage, 
the more they marketed the products and related to it. 
 
Whether age was a factor influencing the performance of a medical representative was 
the other objective of this study. The findings reveal that age does not affect the 
performance of medical representatives. Pharmaceutical products could be marketed by 
those in both ages, what mattered were the outcome and output measures put by the 
pharmaceutical companies. 
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The study did find out that public perception highly affected the performance of the 
medical representative. The higher the public perceived the pharmaceutical company, the 
higher they perceived their products, which may not necessarily be of good quality.  
 
5.2 Recommendations 
The following are recommended in response to the findings revealed by this study;   
Training of medical representatives to boost their technical knowhow needs to be taken 
seriously by Dawa Pharmaceutical Company. They need to have fully fledged training 
department headed by qualified and registered pharmacist in the next financial year and 
allocate a budget for it when they will be doing their projections and budget for 2016.  
This is because currently there is no proper guideline as far as training is concerned. 
Training is critical since the scope of their work borders on both the subject of life and 
death. The need to relook at the training curriculum of medical representatives would 
enable appropriate ways of measuring performance of medical representatives as well.   
 
The study also recommends use of integration of ICT at Dawa pharmaceutical company. 
This situation would enable efficient communication between all departments in the 
company. The communication would enable production and utilization of better products. 
This should be done through enforcement of strict standards for all the departments that 
are involved in the drug manufacturing process. The group ICT manager leads to lead the 
process in the next six months because currently the company has budget that has not 
been utilized. Hence post market surveillance hardly takes place. 
 
5.3 Research Limitations 
There were difficulties in accessing most retail chemists as they feared that they were 
being spied on by Pharmacy and Poisons Board. Getting  access to  some information at 
Dawa  proved to be difficult  owing  to the attachment pharmaceutical  companies has  on 
confidentiality: the researcher  had to produce a letter  from this learning institution  to 
prove that  he was actually a student collecting  data  for his research to enable him meet 
the course requirement. 
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5.3 Conclusion 
In conclusion, usage of ICT, age of medical of medical representatives, training on 
pharmaceutical products and public perception does influence the performance of 
medical representatives.  
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APPENDIX I: LETTER OF INTRODUCTION 
 
To whom it may Concern 
 
RE: ACADEMIC RESEARCH ON ASSESSING THE ROLE OF INFORMATION 
COMMUNICATION TECHNOLOGY ON PERFORMANCE OF 
PHARMACEUTICAL INDUSTRIES IN KENYA 
 
My name is Meshack Okok, am a student of MBA at Management University of Africa 
conducting an academic research, as part of requirement in fulfillment for degree of 
Masters of Business Administration of Management University of Africa.  I wish to 
request your permission to spend 30 minutes with you to assist me with information that 
will help me achieve this endeavor. The information collected in this schedule is purely 
for academic purposes and shall not be shared with anyone except the examiners. Your 
identity will not be revealed to any one and information herein will be treated with 
utmost confidentiality 
 
Yours Sincerely 
 
 
Meshack Okok 
MBA/2/00004/3/2014 
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APPENDIX 11: RESEARCH STUDY QUESTIONNAIRE TO MEDICAL 
REPRESENTATIVES 
 
Questionnaire number Date of administration.  
 
Please respond to the following questionnaire to the best of your ability. 
 
SECTION  A: BACKGROUND  INFORMATION 
What is your gender? 
Male 
Female 
 
Please state your age Bracket 
Between 18- 30 years 
Between  31-40 years. 
Between  41- 50 years 
Above  50  years 
 
Please state the highest Education level you have attained. 
Secondary. 
College. 
University. 
Other 
 
How about the number of years regarding your work experience. 
Less  than one year. 
Between 1- 4  years. 
Between  5- 10 years. 
Above    10 years. 
 
iii 
 
SECTION B:  ICT USAGE 
Where do you place information technology in your work? 
High 
Moderate. 
Low 
 
Do you think InformationTechnology has an effect toyour work? 
Yes. 
No. 
Please Explain this effect 
……………………………………………………………………………………………… 
 
Do you think introduction of informationtechnology can change the perception of 
pharmaceutical consumers? 
Yes. 
No. 
Please explain this effect ………………………………………………………………… 
 
To what extent has Information Communication Technology improved communication in 
the pharmaceutical industry? 
Very Much 
Moderate. 
No improvement. 
 
SECTION C: PRODUCTS EDUCATION  
Would you prefer more education in pharmaceutical products, or in marketing, or in both 
of them so as to enhance your performance?  Response…………………………..……… 
Please Explain this fact further …………………………………………………………… 
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What other factors, other than education stated above influence your performance as a 
medical representative for Dawa Pharmaceuticals?..................…………………………… 
……………………………………………………………………………………………… 
 
Please explain in detail each of these factors mentioned above 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
Whatother measures needs to be put in place to enhance effective performance by your 
employer……………………………………………………………………………… 
 
SECTION D: MEDICAL REPRESENTATIVES AGE 
What is your age bracket? 
Between 20- 30  years . 
Between  31- 40 years . 
Above    40 years. 
 
Do you feel your age have anything to do with your performance, Please explain  
................................................................................................................................................
............................................................................................................................................... 
Supposing some policies were to be made regarding the age of medical representatives, 
which areas would be of interest to you and why?................................................................ 
............................................................................................................................................... 
 
Do you think consideration of age is important in this profession, please explain your 
response……………………………………….………………………………………….. 
……………………………………………………………………………………………. 
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SECTION E – Public Perception 
What is your perception towards local pharmaceuticals companies?............................. 
………………………………………………………………………………………… 
………………………………………………………………………………………… 
 
What do your customers think about local pharmaceutical company products? 
 
Thank you for your response to this questionnaire, kindly is assured this response is for 
the purpose of academic research only. 
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APPENDIX III: RESEARCH STUDY QUESTIONNAIRE TO CHEMIST 
OWNERS 
Questionnaire number Date of administration.  
 
Please respond to the following questionnaire to the best of your ability. 
1. What is the size of your business? 
 
Retail  
Wholesale & Retail 
Other 
 
2. Do you think medical representatives have an influence in your work? 
   Yes      
   No                    
3. Please explain your answers in regards to question 2 above 
4. Do you think your work as a chemist has an influence in medical representatives’ work? 
   Yes      
   No                    
 
5. Please explain your answers in regards to question 4 above, 
6. What sort of education would you prefer for a medical representative that you feel would 
make your work, and theirs easier and effective?_________________________________ 
________________________________________________________________________ 
7. In your opinion, does age affect the performance of medical representatives? 
8. Still on matters of age, how would you relate it to their outcomes, and outputs of the 
performance of medical representatives? 
Age bracket Performance Output Performance Outcome 
20 – 30 years   
30 – 40 years   
Above 40 years   
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9. Please comment further on how these indicators (output and outcomes) of medical 
representative’s influences performance of your business? 
 
 
10. How would you like to work with the medical representatives to make your work 
efficient and effective? 
 
 
11. What is your perception towards usage of local pharmaceutical products? 
 
______________________________________________________________________ 
 
Thank you for your response to this questionnaire, kindly be assured this response is for 
the purpose of academic research only. 
 
 
APPENDIX 1V: RESEARCH STUDY QUESTIONNAIRE TO BIO CHEMIST 
Questionnaire number Date of administration.  
 
Please respond to the following questionnaire to the best of your ability. 
 
1. Do you work or interact with medical representatives in the course of your work? 
Yes  
             No  
 
2. Do you think your performance influence performance of medical representatives?  
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3. Please explain your response  in question 3 above 
________________________________________________________________________
___________________________________________________________________ 
4. Do you think the performance of medical representatives affect your performance  
 
5. Please explain in our response above 
________________________________________________________________________
________________________________________________________________________ 
 
6. What other measures need to be put in place to enhance your performance and that of 
medical representatives?  
 
Thank you for your response to this questionnaire, kindly be assured this response is for 
the purpose of academic research only. 
 
 
